DelveInsight's analysis indicates a promising outlook for the dry eye disease market from 2024 to 2034, with positive growth anticipated. This growth trajectory is attributed to the emergence ...

DelveInsight's Dry Eye Disease Market Insights report includes a comprehensive understanding of current treatment practices, ...

Goldman Sachs is saying good things about this blue chip stock. The post 1 big reason to buy CSL shares now appeared first on ...

Arcturus Therapeutics Holdings Inc. stock is down 46% since Sept. 2023 coverage; mRNA sector faces headwinds with public ...

Doomsday Clock is now the closest to midnight since its introduction in 1947. The symbolic clock now reads 89 seconds to ...

Three ASX shares that brokers have named as buys this week are listed below. Here's why their analysts are feeling bullish on them right now: ...

Artificial Intelligence (AI) was a buzzword around Wall Street for most of 2024. AI has shown immense promise but comes with ...

Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced compelling ...

Rising demand for precision medicine & groundbreaking innovations in RNA sequencing drive growth in oncology, drug discovery, & personalized therapies.

Strong government Investments and Precision medicine Propel Growth in Sanger Sequencing Market, Expected to Quadruple Its Size Over the Next Decade ...

India's life sciences sector expects government reforms in the upcoming Union Budget to support growth and innovation. Key ...

CHEMICAL DIVISIONS WITH SALES AT PREVIOUS YEAR'S LEVEL AMID WEAK MARKET ENVIRONMENT; BIOTECHNOLOGY ABOVE PREVIOUS YEAR; POLYSILICON BELOW PREVIOUS YEAR WITH SOLID SEMICONDUCTOR BUSINESS DESPITE ...